Trials / Active Not Recruiting
Active Not RecruitingNCT07255170
RED BEAN AND TOMATO SNACK BAR FORMULATIONS AS A HEALTHY SNACK FOR DIABETES MELLITUS PATIENTS
DEVELOPMENT OF "GLYCEMIC CONTROL BAR WITH BEANS AND TOMATO FOR DIABETIC EATING" (GLYCOBITE) SNACK BAR FORMULATIONS AS A HEALTHY SNACK FOR DIABETES MELLITUS PATIENTS
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- University Ngudi Waluyo · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to develop a "GlycoBite" snack bar formulation combination of red beans and tomatoes, and to assess its acceptability, nutritional content, and effectiveness on blood glucose levels in diabetic patients. The main questions it aims to answer are: 1. Dose snack bar formulation combination of red beans and tomatoes as a potensial healthy snack for diabetic patients? 2. Does snack bar formulation combination of red beans and tomatoes improve glycemic control 3. Does snack bar formulation combination of red beans and tomatoes lower blood glucose
Detailed description
Researchers will compare GlycoBite (red beans and tomato combine) snack bar to commercial snack bar to see if GlycoBite works to control blood glucose Participants will: 1. Take 40 grams of GlycoBite or commercial snack bar every day for 3 weeks 2. Weekly fasting blood glucose monitoring and evaluations were carried out. 3. Monitoring glycemic control ( HbA1c Levels) before and after intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | The GlycoBite snack bar formula created is to combine tomatoes and red beans in a ratio of 60% and 40% respectively. Participants consuming 40 grams of "GlycoBite" snack bars daily | Participants consuming 40 grams of "GlycoBite" snack bars daily for 3 weeks |
Timeline
- Start date
- 2025-08-15
- Primary completion
- 2025-11-20
- Completion
- 2025-11-22
- First posted
- 2025-11-28
- Last updated
- 2025-11-28
Locations
1 site across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT07255170. Inclusion in this directory is not an endorsement.